Page last updated: 2024-11-04

risedronic acid and Attachment Loss, Periodontal

risedronic acid has been researched along with Attachment Loss, Periodontal in 1 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Research Excerpts

ExcerptRelevanceReference
"The present study was designed to evaluate the effects of risedronate, one of the most potent bisphosphonates, on alveolar bone resorption and angiogenesis in rats with experimental periodontitis to identify dose-response curves and treatment durations that can be therapeutic for periodontal therapy versus those associated with osteonecrosis of the jaws."1.35Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats. ( Ayas, B; Cetinkaya, BO; Gurgor, P; Keles, GC, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cetinkaya, BO1
Keles, GC1
Ayas, B1
Gurgor, P1

Other Studies

1 other study available for risedronic acid and Attachment Loss, Periodontal

ArticleYear
Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats.
    Journal of periodontology, 2008, Volume: 79, Issue:10

    Topics: Alveolar Bone Loss; Alveolar Process; Animals; Blood Vessels; Bone Density; Bone Density Conservatio

2008